• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾衰竭风险方程在哥伦比亚人群中的验证。

Validation of the Kidney Failure Risk Equation in the Colombian Population.

作者信息

Larrarte C, Vesga J, Ardila F, Aldana A, Perea D, Sanabria M

机构信息

Baxter Renal Care Services, Bucaramanga, Colombia.

Baxter Renal Care Services-Latin America, Bogotá, Colombia.

出版信息

Int J Nephrol. 2024 Feb 17;2024:1282664. doi: 10.1155/2024/1282664. eCollection 2024.

DOI:10.1155/2024/1282664
PMID:38405300
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10894049/
Abstract

INTRODUCTION

Chronic kidney disease prevention programs must identify patients at risk of early progression to provide better treatment and prolong kidney replacement therapy-free survival. Risk equations have been developed and validated in cohorts outside of Colombia, so this study aims to evaluate the discrimination and calibration of the four-variable kidney failure risk equation in a Colombian population where it has yet to be validated.

METHODS

External validation study of a kidney failure risk equation using a historical cohort of patients with CKD stages 3, 4, and 5, adults without a history of dialysis or kidney transplantation with a two-year follow-up, belonging to the Baxter Renal Care Services Colombia network. The discriminatory capacity of the model was evaluated by the concordance index using Harrell's C statistic, and the time-dependent area under the receiver operating characteristic (ROC) curve was estimated using the nearest neighbor method, as well as the optimal cut-off point for sensitivity and specificity. Calibration was determined by the degree of agreement between the observed outcome and the probabilities predicted by the model using the Hosmer-Lemeshow statistic.

RESULTS

A total of 5,477 patients were included, with a mean age of 72 years, 36.4% diabetic, and a mean baseline eGFR of 36 ml/min/1.73 m. The rate of dialysis initiation was three events per 100 patient-years, 95% CI (2.9-3.6). The optimal cutoff for sensitivity was 0.94, for specificity, 0.76, and the area under the ROC curve was 0.92. Harrell's C-statistic was 0.88 for the total population, 0.88 for diabetic patients, and 0.93 for those 65 years or older. The validation of the model showed good calibration.

CONCLUSIONS

In this Colombian cohort, the four-variable KFRE with a two-year prediction horizon has excellent calibration and discrimination, and its use in the care of CKD Colombian patients is recommended.

摘要

引言

慢性肾脏病预防项目必须识别有早期进展风险的患者,以便提供更好的治疗并延长无肾脏替代治疗的生存期。风险方程已在哥伦比亚以外的队列中开发并验证,因此本研究旨在评估四变量肾衰竭风险方程在尚未验证的哥伦比亚人群中的辨别力和校准情况。

方法

对肾衰竭风险方程进行外部验证研究,使用来自哥伦比亚百特肾脏护理服务网络的慢性肾脏病3、4、5期成年患者的历史队列,这些患者无透析或肾移植史,随访两年。使用Harrell's C统计量通过一致性指数评估模型的辨别能力,使用最近邻法估计受试者工作特征(ROC)曲线下的时间依赖性面积,以及敏感性和特异性的最佳截断点。使用Hosmer-Lemeshow统计量通过观察到的结果与模型预测的概率之间的一致程度来确定校准情况。

结果

共纳入5477例患者,平均年龄72岁,36.4%为糖尿病患者,平均基线估算肾小球滤过率(eGFR)为36 ml/min/1.73 m²。透析起始率为每100患者年3例事件,95%置信区间(2.9 - 3.6)。敏感性的最佳截断值为0.94,特异性为0.76,ROC曲线下面积为0.92。总体人群的Harrell's C统计量为0.88,糖尿病患者为0.88,65岁及以上患者为0.93。模型验证显示校准良好。

结论

在这个哥伦比亚队列中,具有两年预测期的四变量KFRE具有出色的校准和辨别力,建议将其用于哥伦比亚慢性肾脏病患者的护理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3852/10894049/6e079d2702a1/IJN2024-1282664.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3852/10894049/1621eef2cb4f/IJN2024-1282664.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3852/10894049/b0a915d116e6/IJN2024-1282664.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3852/10894049/6e079d2702a1/IJN2024-1282664.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3852/10894049/1621eef2cb4f/IJN2024-1282664.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3852/10894049/b0a915d116e6/IJN2024-1282664.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3852/10894049/6e079d2702a1/IJN2024-1282664.003.jpg

相似文献

1
Validation of the Kidney Failure Risk Equation in the Colombian Population.肾衰竭风险方程在哥伦比亚人群中的验证。
Int J Nephrol. 2024 Feb 17;2024:1282664. doi: 10.1155/2024/1282664. eCollection 2024.
2
A validation study of the kidney failure risk equation in advanced chronic kidney disease according to disease aetiology with evaluation of discrimination, calibration and clinical utility.根据病因对晚期慢性肾脏病的肾衰竭风险方程进行验证研究,评估其区分度、校准度和临床实用性。
BMC Nephrol. 2021 May 24;22(1):194. doi: 10.1186/s12882-021-02402-1.
3
Validation of the kidney failure risk equation in a Portuguese cohort.验证在葡萄牙队列中衰竭风险方程。
Nefrologia (Engl Ed). 2023 Jul-Aug;43(4):467-473. doi: 10.1016/j.nefroe.2022.03.007. Epub 2022 Dec 16.
4
Performance of the Kidney Failure Risk Equation by Disease Etiology in Advanced CKD.按疾病病因对晚期慢性肾脏病中肾衰竭风险方程的性能评估。
Clin J Am Soc Nephrol. 2020 Oct 7;15(10):1424-1432. doi: 10.2215/CJN.03940320. Epub 2020 Sep 14.
5
External Validation of the Kidney Failure Risk Equation Among Urban Community-Based Chinese Patients With CKD.中国城市社区慢性肾脏病患者肾衰竭风险方程的外部验证
Kidney Med. 2024 Mar 26;6(5):100817. doi: 10.1016/j.xkme.2024.100817. eCollection 2024 May.
6
Validation of the kidney failure risk equation in European CKD patients.验证欧洲慢性肾脏病患者的肾衰竭风险方程。
Nephrol Dial Transplant. 2013 Jul;28(7):1773-9. doi: 10.1093/ndt/gft063. Epub 2013 May 3.
7
External validation of the KFRE and Grams prediction models for kidney failure and death in a Spanish cohort of patients with advanced chronic kidney disease.KFRE 和 Grams 预测模型在西班牙晚期慢性肾脏病患者队列中对肾衰竭和死亡的外部验证。
J Nephrol. 2024 Mar;37(2):429-437. doi: 10.1007/s40620-023-01819-1. Epub 2023 Dec 7.
8
The Kidney Failure Risk Equation for prediction of end stage renal disease in UK primary care: An external validation and clinical impact projection cohort study.用于预测英国初级保健中终末期肾病的肾衰竭风险方程:外部验证和临床影响预测队列研究。
PLoS Med. 2019 Nov 6;16(11):e1002955. doi: 10.1371/journal.pmed.1002955. eCollection 2019 Nov.
9
Validation of the kidney failure risk equation in predicting the risk of progression to kidney failure in a multi-ethnic Singapore chronic kidney disease cohort.验证肾衰竭风险方程在预测新加坡多民族慢性肾脏病队列进展为肾衰竭风险中的作用。
Singapore Med J. 2022 Jun;63(6):313-318. doi: 10.11622/smedj.2020170. Epub 2020 Dec 2.
10
Validation of the Kidney Failure Risk Equation in Kidney Transplant Recipients.肾衰竭风险方程在肾移植受者中的验证
Can J Kidney Health Dis. 2020 May 25;7:2054358120922627. doi: 10.1177/2054358120922627. eCollection 2020.

本文引用的文献

1
Multicentre external validation of the prognostic model kidney failure risk equation in patients with CKD stages 3 and 4 in Peru: a retrospective cohort study.秘鲁慢性肾脏病 3 期和 4 期患者中预测模型肾衰竭风险方程的多中心外部验证:回顾性队列研究。
BMJ Open. 2024 Jan 6;14(1):e076217. doi: 10.1136/bmjopen-2023-076217.
2
Chronic Kidney Disease: Strategies to Retard Progression.慢性肾脏病:延缓进展的策略。
Int J Mol Sci. 2021 Sep 18;22(18):10084. doi: 10.3390/ijms221810084.
3
Chronic Kidney Disease Progression and Transition Probabilities in a Large Preventive Cohort in Colombia.
哥伦比亚一个大型预防队列中的慢性肾脏病进展及转变概率
Int J Nephrol. 2021 Mar 31;2021:8866446. doi: 10.1155/2021/8866446. eCollection 2021.
4
Kidney Failure Prediction Models: A Comprehensive External Validation Study in Patients with Advanced CKD.肾衰竭预测模型:晚期慢性肾脏病患者的综合外部验证研究。
J Am Soc Nephrol. 2021 May 3;32(5):1174-1186. doi: 10.1681/ASN.2020071077. Epub 2021 Mar 8.
5
Influence of Mortality on Estimating the Risk of Kidney Failure in People with Stage 4 CKD.死亡对估计 4 期 CKD 患者肾衰竭风险的影响。
J Am Soc Nephrol. 2019 Nov;30(11):2219-2227. doi: 10.1681/ASN.2019060640. Epub 2019 Sep 20.
6
[Program for the prevention of chronic kidney disease based on integrated service networks in Colombia].[基于哥伦比亚综合服务网络的慢性肾脏病预防项目]
Rev Salud Publica (Bogota). 2017 Mar-Apr;19(2):171-176. doi: 10.15446/rsap.v19n2.45110.
7
Pro: Risk scores for chronic kidney disease progression are robust, powerful and ready for implementation.优点:慢性肾脏病进展风险评分可靠、有效且可随时实施。
Nephrol Dial Transplant. 2017 May 1;32(5):748-751. doi: 10.1093/ndt/gfx067.
8
Multinational Assessment of Accuracy of Equations for Predicting Risk of Kidney Failure: A Meta-analysis.预测肾衰竭风险方程准确性的多国评估:一项荟萃分析。
JAMA. 2016 Jan 12;315(2):164-74. doi: 10.1001/jama.2015.18202.
9
Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline.慢性肾脏病的评估与管理:肾脏病:改善全球预后 2012 临床实践指南概要。
Ann Intern Med. 2013 Jun 4;158(11):825-30. doi: 10.7326/0003-4819-158-11-201306040-00007.
10
A systematic review finds prediction models for chronic kidney disease were poorly reported and often developed using inappropriate methods.一项系统评价发现,用于慢性肾脏病的预测模型报告情况不佳,且常常使用不当的方法开发。
J Clin Epidemiol. 2013 Mar;66(3):268-77. doi: 10.1016/j.jclinepi.2012.06.020. Epub 2012 Oct 30.